Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-09-26
1992-10-13
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514418, 514507, 514575, 544285, 544287, 548483, 560315, 562622, C07C25910, A61K 3127
Patent
active
051551101
ABSTRACT:
The present invention is novel selected hydroxamic acid derivatives of fenamic acids having 5-lipoxygenase and cyclooxygenase inhibiting properties, pharmaceutical compositions for treating conditions advantageously affected by the inhibition and methods for treating these conditions in mammals, including humans suffering therefor.
REFERENCES:
patent: 4029815 (1977-06-01), Sherlock
patent: 4906667 (1990-03-01), Varma
Wolf and Kohn; Liebigs Ann. Chem. 1975, 1245-1251 "Cyclisierungsreaktionen von am Aminostickstoff Substituierten o-Aminobenzhydroxamsaure-O-methylestern".
James B. Summers, et al., "Hydroxamic Acid Inhibitors of 5-Lipoxygenase" J. Med. Chem 1987, 30, 574-580.
Summers, et al. "In Vivo Characterization of Hydroxamic Acid Inhibitors of 5-Lipoxygenase" Sep. 1987, (Abstract).
Connor David T.
Flynn Daniel L.
Daignault Ronald A.
Gerstl Robert
Thierstein Joan
Warner-Lambert & Company
LandOfFree
Fenamic acid hydroxamate derivatives having cyclooxygenase and 5 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fenamic acid hydroxamate derivatives having cyclooxygenase and 5, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fenamic acid hydroxamate derivatives having cyclooxygenase and 5 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1300595